» Articles » PMID: 34138796

Neurodevelopmental Effects of Cannabis Use in Adolescents and Emerging Adults with ADHD: A Systematic Review

Overview
Specialty Psychiatry
Date 2021 Jun 17
PMID 34138796
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Systematically review the scientific literature to characterize the effects of cannabis use on brain structure, function, and neurodevelopmental outcomes in adolescents and young adults with ADHD.

Method: Systematic review following PRISMA guidelines utilizing PubMed, Embase, PsycINFO, and Cochrane CENTRAL trials register from inception until 1 January 2020. Articles that examined the impact of cannabis use on youth with ADHD were included.

Results: Eleven studies were identified that compared outcomes for individuals with ADHD who used cannabis or synthetic cannabinoids against those with ADHD who did not. Seven of these studies used neuroimaging techniques, including fMRI, structural MRI, and SPECT. Differential regions of activation were identified, including the right hippocampus and cerebellar vermis, and bilateral temporal lobes. Morphological differences were identified in the right precentral and postcentral gyri, left nucleus accumbens, right superior frontal and postcentral gyri. No study identified any additive or ADHD × cannabis use interaction on neuropsychological tasks of executive function. Two studies found adverse differential impacts of early-onset cannabis use in this population.

Conclusion: A dearth of evidence is available on the impact of cannabis use on the developing brain and functioning for individuals with ADHD, despite the elevated risk for substance use in this population. The limited, potentially underpowered evidence does not support the hypothesis that cannabis use has a deleterious impact on neuropsychological tasks in transitional age youth with ADHD. Larger and longer-term studies are needed, however, to better inform clinicians and patients as to the impacts of cannabis use in youth with ADHD.

Citing Articles

Adolescent Substance Use Disorders.

Simon K, Levy S, Bukstein O NEJM Evid. 2024; 1(6):EVIDra2200051.

PMID: 38319247 PMC: 11003516. DOI: 10.1056/EVIDra2200051.


Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic Review.

Dhamija D, Bello A, Khan A, Gutlapalli S, Sohail M, Patel P Cureus. 2023; 15(6):e40969.

PMID: 37503496 PMC: 10370827. DOI: 10.7759/cureus.40969.


Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician.

Barbuti M, Maiello M, Spera V, Pallucchini A, Brancati G, Maremmani A J Clin Med. 2023; 12(9).

PMID: 37176536 PMC: 10179386. DOI: 10.3390/jcm12093096.

References
1.
Mitchell J, Weisner T, Jensen P, Murray D, Molina B, Eugene Arnold L . How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning. J Atten Disord. 2017; 22(9_suppl):49S-60S. PMC: 5538943. DOI: 10.1177/1087054716685842. View

2.
Jepsen J, Fagerlund B, Mortensen E . Do attention deficits influence IQ assessment in children and adolescents with ADHD?. J Atten Disord. 2008; 12(6):551-62. DOI: 10.1177/1087054708322996. View

3.
Harstad E, Wisk L, Ziemnik R, Huang Q, Salimian P, Weitzman E . Substance Use Among Adolescents with Attention-Deficit/Hyperactivity Disorder: Reasons for Use, Knowledge of Risks, and Provider Messaging/Education. J Dev Behav Pediatr. 2017; 38(6):417-423. PMC: 5505316. DOI: 10.1097/DBP.0000000000000461. View

4.
Rasmussen J, Casey B, van Erp T, Tamm L, Epstein J, Buss C . ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task. Brain Imaging Behav. 2015; 10(3):761-71. PMC: 4840078. DOI: 10.1007/s11682-015-9438-9. View

5.
Biederman J, Faraone S . The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed. 2007; 8(3):12. PMC: 1781280. View